JPH11507017A5 - - Google Patents

Info

Publication number
JPH11507017A5
JPH11507017A5 JP1996534120A JP53412096A JPH11507017A5 JP H11507017 A5 JPH11507017 A5 JP H11507017A5 JP 1996534120 A JP1996534120 A JP 1996534120A JP 53412096 A JP53412096 A JP 53412096A JP H11507017 A5 JPH11507017 A5 JP H11507017A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1996534120A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11507017A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1996/006119 external-priority patent/WO1996035678A1/en
Publication of JPH11507017A publication Critical patent/JPH11507017A/ja
Publication of JPH11507017A5 publication Critical patent/JPH11507017A5/ja
Withdrawn legal-status Critical Current

Links

JP8534120A 1995-05-08 1996-05-03 ウイルス逆転写酵素の阻害剤としてのα−置換のピリミジン−チオアルキルおよびアルキルエーテル化合物 Withdrawn JPH11507017A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43670895A 1995-05-08 1995-05-08
US08/436,708 1995-05-08
PCT/US1996/006119 WO1996035678A1 (en) 1995-05-08 1996-05-03 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase

Publications (2)

Publication Number Publication Date
JPH11507017A JPH11507017A (ja) 1999-06-22
JPH11507017A5 true JPH11507017A5 (https=) 2004-07-08

Family

ID=23733510

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8534120A Withdrawn JPH11507017A (ja) 1995-05-08 1996-05-03 ウイルス逆転写酵素の阻害剤としてのα−置換のピリミジン−チオアルキルおよびアルキルエーテル化合物

Country Status (26)

Country Link
US (1) US6043248A (https=)
EP (2) EP0824524B1 (https=)
JP (1) JPH11507017A (https=)
KR (1) KR100445498B1 (https=)
CN (2) CN1535958A (https=)
AT (1) ATE275550T1 (https=)
AU (1) AU712404B2 (https=)
BR (1) BR9608265A (https=)
CA (1) CA2216099C (https=)
CZ (1) CZ293135B6 (https=)
DE (1) DE69633332T2 (https=)
ES (1) ES2227586T3 (https=)
GE (1) GEP20002297B (https=)
HU (1) HUP9801995A3 (https=)
IL (1) IL118075A0 (https=)
MX (1) MX9708582A (https=)
NO (1) NO310287B1 (https=)
NZ (1) NZ307089A (https=)
PL (1) PL323240A1 (https=)
PT (1) PT824524E (https=)
RU (1) RU2167155C2 (https=)
SK (1) SK150297A3 (https=)
TW (1) TW450962B (https=)
UA (1) UA56992C2 (https=)
WO (1) WO1996035678A1 (https=)
ZA (1) ZA963281B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034167A1 (en) * 1997-09-25 2000-09-13 PHARMACIA & UPJOHN COMPANY Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors
US6111111A (en) 1997-10-23 2000-08-29 Kuraray Co., Ltd. Intermediates for producing pyridine derivatives
US7358254B2 (en) 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
TR200100773T2 (tr) 1998-09-17 2001-07-23 Bristol-Myers Squibb Company Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı diyabet tedavi yöntemi
WO2001000214A1 (en) 1999-06-30 2001-01-04 Merck & Co., Inc. Src kinase inhibitor compounds
JP2003503351A (ja) 1999-06-30 2003-01-28 メルク エンド カムパニー インコーポレーテッド Srcキナーゼ阻害化合物
AU5636900A (en) 1999-06-30 2001-01-31 Merck & Co., Inc. Src kinase inhibitor compounds
US7138404B2 (en) * 2001-05-23 2006-11-21 Hoffmann-La Roche Inc. 4-aminopyrimidine derivatives
MX2007006635A (es) * 2004-12-03 2007-06-19 Merck & Co Inc Formulacion farmaceutica de inhibidores dela carboxamida vih integrasa que contienen una composicion que controla la velocidad de liberacion.
US20080214588A1 (en) * 2005-03-04 2008-09-04 Herman Augustinus De Kock Hiv Inhibiting 2-(4-Cyanophenyl)-6-Hydroxylaminopyrimidines
US7923056B2 (en) 2007-06-01 2011-04-12 Illinois Tool Works Inc. Method and apparatus for dispensing material on a substrate
AR076601A1 (es) 2009-05-21 2011-06-22 Chlorion Pharma Inc Pirimidinas como agentes terapeuticos
CN101638391B (zh) * 2009-08-21 2011-04-27 山东大学 2-[(取代苯氨基)羰基甲硫基]-6-(2,6-二氯苄基)-3h-嘧啶-4-酮类衍生物及其制备方法与应用
US9226970B2 (en) 2010-02-22 2016-01-05 Nektar Therapeutics Oligomer modified diaromatic substituted compounds
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
AP2013006706A0 (en) * 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
KR101360587B1 (ko) * 2012-11-01 2014-03-10 현대자동차주식회사 스마트 도어 언록 시스템
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
MY197231A (en) 2015-07-22 2023-06-06 Enanta Pharm Inc Benzodiazepine derivatives as rsv inhibitors
GB201807898D0 (en) * 2018-05-15 2018-06-27 Kancera Ab New processes and products with increased chiral purity
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
AU2020357452B2 (en) * 2019-10-04 2026-01-29 Enanta Pharmaceuticals, Inc Antiviral heterocyclic compounds
US20230112484A1 (en) * 2020-01-20 2023-04-13 Agrematch Ltd. Compositions for crop protection
UY39892A (es) 2021-08-10 2023-03-31 Novartis Pharma Ag Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING
CN114057707A (zh) * 2021-11-24 2022-02-18 上海应用技术大学 一种n-4-吲哚基-2-呋喃甲酰胺化合物的制备方法
EP4463441A1 (en) * 2022-01-12 2024-11-20 IFM Due, Inc. Compounds and compositions for treating conditions associated with sting activity

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2295560A (en) * 1941-06-18 1942-09-15 Gen Electric Pyrimidine derivatives
GB744867A (en) * 1952-10-29 1956-02-15 American Cyanamid Co Improvements relating to 2-substituted-mercapto-4-amino-6-disubstituted-aminopyrimidines and acid addition salts thereof
US3940394A (en) * 1972-03-31 1976-02-24 Santilli Arthur A 2-pyrimidinylthio)alkanoic acids, esters, amides and hydrazides
US3940240A (en) * 1974-07-11 1976-02-24 Ina Seito Co., Ltd. Baking method and kiln for tile
DE3369514D1 (en) * 1983-05-05 1987-03-05 Heumann Ludwig & Co Gmbh Pyrimidinethioalkyl pyridine derivatives, process for their preparation and medicines containing these compounds
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
JPS62209062A (ja) * 1986-03-10 1987-09-14 Yamanouchi Pharmaceut Co Ltd 2−ピリジルメチルチオ−または2−ピリジルメチルスルフイニル−置換縮合環化合物
JPH07107056B2 (ja) * 1987-01-30 1995-11-15 日清製粉株式会社 4(3h)−キナゾリノン誘導体、その製造方法およびそれを有効成分とする抗潰瘍剤
WO1989011279A1 (en) * 1988-05-16 1989-11-30 Georgia State University Foundation, Inc. Nucleic acid interacting unfused heteropolycyclic compounds
HU203736B (en) * 1989-04-06 1991-09-30 Gyogyszerkutato Intezet Process for producing new thiouracil-derivatives and pharmaceutical compositions containing them
HK1002235A1 (en) * 1989-12-28 1998-08-07 Pharmacia & Upjohn Company Diaromatic substituted anti-aids compounds
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
DE69217224T2 (de) * 1991-07-03 1997-06-05 Pharmacia & Upjohn Co., Kalamazoo, Mich. Substituierte indole als anti-aids pharmaceutische zubereitungen
GB2266716A (en) * 1992-05-05 1993-11-10 Merck & Co Inc Inhibitors of HIV reverse transcriptase
JP3077046B2 (ja) * 1992-08-31 2000-08-14 久光製薬株式会社 新規なキナゾリン誘導体
EP0720607A1 (en) * 1993-09-17 1996-07-10 PHARMACIA & UPJOHN COMPANY Substituted tetronic acids useful for treating hiv and other retroviruses
JPH09505050A (ja) * 1993-11-12 1997-05-20 ジ・アップジョン・カンパニー ピリミジン−チオアルキルおよびアルキルエーテル化合物
WO1995029897A1 (en) * 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
RU2149872C1 (ru) * 1994-07-20 2000-05-27 Бык Гульден Ломберг Хемише Фабрик Гмбх Пиридилтиосоединения для борьбы с бактериями helicobacter

Similar Documents

Publication Publication Date Title
JP2000500033A5 (https=)
JP2000500228A5 (https=)
JP2000500445A5 (https=)
JP2000500440A5 (https=)
JPH11509126A5 (https=)
JPH11505146A5 (https=)
JP2000500327A5 (https=)
JP2000500145A5 (https=)
JP2000500155A5 (https=)
JP2000500406A5 (https=)
JP2000500892A5 (https=)
JP2000500361A5 (https=)
JP2000500322A5 (https=)
JP2000500258A5 (https=)
JPH11512439A5 (https=)
JP2000500342A5 (https=)
JP2000500192A5 (https=)
JP2000500226A5 (https=)
JP2000500051A5 (https=)
JP2000500166A5 (https=)
JP2000500407A5 (https=)
JP2000500397A5 (https=)
JP2000500019A5 (https=)
JPH11507017A5 (https=)
JP2000500125A5 (https=)